| Primary |
| Product Used For Unknown Indication |
23.4% |
| Hypersensitivity |
16.5% |
| Drug Use For Unknown Indication |
13.0% |
| Multiple Allergies |
5.6% |
| Hypertension |
5.2% |
| Pruritus |
5.2% |
| Urticaria |
4.5% |
| Rash |
2.8% |
| Sleep Disorder |
2.6% |
| Insomnia |
2.5% |
| Suicide Attempt |
2.4% |
| Sleep Disorder Therapy |
2.4% |
| Premedication |
2.0% |
| Pain |
2.0% |
| Anxiety |
1.9% |
| Depression |
1.7% |
| Cardiac Disorder |
1.7% |
| Gastrooesophageal Reflux Disease |
1.6% |
| Food Allergy |
1.5% |
| Migraine |
1.5% |
|
| Off Label Use |
11.1% |
| Vomiting |
10.6% |
| Somnolence |
9.5% |
| Overdose |
6.5% |
| Urticaria |
6.5% |
| Product Quality Issue |
6.3% |
| Throat Tightness |
5.6% |
| Hallucination |
4.5% |
| Wrong Drug Administered |
4.1% |
| Hypersensitivity |
3.8% |
| Tremor |
3.8% |
| Weight Decreased |
3.8% |
| Incorrect Dose Administered |
3.6% |
| Loss Of Consciousness |
3.4% |
| Rash |
3.4% |
| Drug Dependence |
2.9% |
| Swelling |
2.9% |
| Swelling Face |
2.7% |
| Respiratory Arrest |
2.5% |
| Convulsion |
2.3% |
|
| Secondary |
| Product Used For Unknown Indication |
25.4% |
| Drug Use For Unknown Indication |
10.6% |
| Premedication |
8.3% |
| Hypersensitivity |
6.6% |
| Pruritus |
5.9% |
| Urticaria |
5.9% |
| Hypertension |
4.0% |
| Multiple Allergies |
3.6% |
| Pain |
3.6% |
| Depression |
3.3% |
| Rash |
3.2% |
| Crohn's Disease |
3.1% |
| Rheumatoid Arthritis |
2.7% |
| Migraine |
2.2% |
| Pyrexia |
2.2% |
| Smoking Cessation Therapy |
2.1% |
| Insomnia |
2.1% |
| Prophylaxis |
2.0% |
| Sleep Disorder |
1.7% |
| Anxiety |
1.4% |
|
| Vomiting |
13.5% |
| Urticaria |
11.4% |
| Drug Hypersensitivity |
8.4% |
| Product Quality Issue |
8.0% |
| Somnolence |
7.1% |
| Off Label Use |
7.0% |
| Weight Increased |
6.2% |
| Rash |
5.0% |
| Tremor |
4.0% |
| Weight Decreased |
3.9% |
| Drug Ineffective |
3.4% |
| Pruritus |
3.3% |
| Swelling |
3.1% |
| Infusion Related Reaction |
2.5% |
| Suicide Attempt |
2.4% |
| Vision Blurred |
2.4% |
| Hypersensitivity |
2.2% |
| Anaphylactic Reaction |
2.1% |
| Dyspnoea |
2.1% |
| Overdose |
2.1% |
|
| Concomitant |
| Product Used For Unknown Indication |
22.0% |
| Premedication |
20.0% |
| Drug Use For Unknown Indication |
13.8% |
| Pain |
5.4% |
| Crohn's Disease |
4.6% |
| Hypertension |
3.5% |
| Prophylaxis |
3.4% |
| Multiple Sclerosis |
3.0% |
| Depression |
2.9% |
| Asthma |
2.7% |
| Rheumatoid Arthritis |
2.5% |
| Nausea |
2.4% |
| Hypersensitivity |
2.2% |
| Insomnia |
2.0% |
| Anxiety |
1.9% |
| Gastrooesophageal Reflux Disease |
1.8% |
| Non-small Cell Lung Cancer |
1.8% |
| Breast Cancer |
1.6% |
| Sleep Disorder |
1.3% |
| Constipation |
1.2% |
|
| Vomiting |
16.7% |
| Urticaria |
10.6% |
| Rash |
6.5% |
| Infusion Related Reaction |
6.0% |
| Weight Increased |
5.6% |
| Weight Decreased |
5.6% |
| Pruritus |
5.2% |
| Tremor |
4.2% |
| Pyrexia |
4.0% |
| Hypersensitivity |
4.0% |
| Pain |
4.0% |
| Nausea |
3.9% |
| White Blood Cell Count Decreased |
3.3% |
| Dyspnoea |
3.3% |
| Wheezing |
3.2% |
| Urinary Tract Infection |
3.0% |
| Drug Ineffective |
2.9% |
| Pulmonary Embolism |
2.8% |
| Death |
2.7% |
| Throat Tightness |
2.7% |
|
| Interacting |
| Ill-defined Disorder |
29.9% |
| Drug Use For Unknown Indication |
18.7% |
| Sleep Disorder |
6.5% |
| Arthralgia |
5.6% |
| Hypersensitivity |
4.7% |
| Product Used For Unknown Indication |
4.7% |
| Bronchitis |
3.7% |
| Cellulitis |
3.7% |
| Insomnia |
3.7% |
| Smoking Cessation Therapy |
2.8% |
| Arthritic Pains |
1.9% |
| Ex-smoker |
1.9% |
| Musculoskeletal Discomfort |
1.9% |
| Rash |
1.9% |
| Schizoaffective Disorder |
1.9% |
| Thyroid Disorder |
1.9% |
| Urticaria |
1.9% |
| Allergy To Animal |
0.9% |
| Antibiotic Therapy |
0.9% |
| Diabetic Neuropathy |
0.9% |
|
| Pollakiuria |
15.2% |
| Drug Interaction |
9.1% |
| Rash |
9.1% |
| Accidental Overdose |
6.1% |
| Dyspnoea |
6.1% |
| Hypersensitivity |
6.1% |
| Urticaria |
6.1% |
| Weight Increased |
6.1% |
| Chills |
3.0% |
| Euphoric Mood |
3.0% |
| Inflammation |
3.0% |
| Infusion Site Extravasation |
3.0% |
| Insomnia |
3.0% |
| Intentional Overdose |
3.0% |
| Ischaemic Cardiomyopathy |
3.0% |
| Loss Of Consciousness |
3.0% |
| Memory Impairment |
3.0% |
| Nasal Congestion |
3.0% |
| Nausea |
3.0% |
| Paraesthesia |
3.0% |
|
